CoChat

Parkin Pathway Activation Mitigates Glioma Cell Proliferation and Predicts Patient Survival

Yeo, Calvin W.S., Ng, Felicia S.L., Chai, Chou, Tan, Jeanne M.M., Koh, Geraldene R.H., Chong, Yuk Kien, Koh, Lynnette W.H., Foong, Charlene S.F., Sandanaraj, Edwin, Holbrook, Joanna D., Ang, Beng-Ti, Takahashi, Ryosuke, Tang, Carol, Lim, Kah-Leong · 2012 · Cancer Research
Cited by 97

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Mutations in the parkin gene, which encodes a ubiquitin ligase, are a major genetic cause of parkinsonism. Interestingly, parkin also plays a role in cancer as a putative tumor suppressor, and the gene is frequently targeted by deletion and inactivation in human malignant tumors. Here, we investigated a potential tumor suppressor role for parkin in gliomas. We found that parkin expression was dramatically reduced in glioma cells. Restoration of parkin expression promoted G1 phase cell-cycle arrest and mitigated the proliferation rate of glioma cells in vitro and in vivo. Notably, parkin-expressing glioma cells showed a reduction in levels of cyclin D1, but not cyclin E, and a selective downregulation of Akt serine-473 phosphorylation and VEGF receptor levels. In accordance, cells derived from a parkin-null mouse model exhibited increased levels of cyclin D1, VEGF receptor, and Akt phosphorylation, and divided significantly faster when compared with wild-type cells, with suppression of these changes following parkin reintroduction. Clinically, analysis of parkin pathway activation was predictive for the survival outcome of patients with glioma. Taken together, our study provides mechanistic insight into the tumor suppressor function of parkin in brain tumors and suggests that measurement of parkin pathway activation may be used clinically as a prognostic tool in patients with brain tumor. Cancer Res; 72(10); 2543–53. ©2012 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-11-3060

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Metadata

Authors
Yeo, C. W. S., Ng, F. S. L., Chai, C., Tan, J. M. M., Koh, G. R. H., Chong, Y. K., Koh, L. W. H., Foong, C. S. F., Sandanaraj, E., Holbrook, J. D., Ang, B.-T., Takahashi, R., Tang, C., & Lim, K.-L.
Venue
Cancer Research
Published
2012-05-14
Volume
72
Issue
10
Pages
2543-2553
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2057201144
Cited by
97
References
3
FWCI
2.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Parkin Pathway Activation Mitigates Glioma Cell Proliferation and Predicts Patient Survival. https://app.cochat.ai/papers/10.1158/0008-5472.can-11-3060
The paper
Yeo, C. W. S., Ng, F. S. L., Chai, C., Tan, J. M. M., Koh, G. R. H., Chong, Y. K., Koh, L. W. H., Foong, C. S. F., Sandanaraj, E., Holbrook, J. D., Ang, B.-T., Takahashi, R., Tang, C., & Lim, K.-L. (2012). Parkin Pathway Activation Mitigates Glioma Cell Proliferation and Predicts Patient Survival. Cancer Research. https://doi.org/10.1158/0008-5472.can-11-3060

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.